WO2007047838A3 - Procede de preparation de l'olmesartan medoxomil - Google Patents

Procede de preparation de l'olmesartan medoxomil Download PDF

Info

Publication number
WO2007047838A3
WO2007047838A3 PCT/US2006/040883 US2006040883W WO2007047838A3 WO 2007047838 A3 WO2007047838 A3 WO 2007047838A3 US 2006040883 W US2006040883 W US 2006040883W WO 2007047838 A3 WO2007047838 A3 WO 2007047838A3
Authority
WO
WIPO (PCT)
Prior art keywords
olmesartan medoxomil
methylethyl
carboxylate
propyl
hydroxy
Prior art date
Application number
PCT/US2006/040883
Other languages
English (en)
Other versions
WO2007047838A2 (fr
Inventor
Sonny Sebastian
Srinivas Reddy Gade
Srinivasa Reddy Mallepalli
Nageswara Rao Koduri
Ravindranath Tagore Amirisetty
Sri Hari Babu Karrothu
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Sonny Sebastian
Srinivas Reddy Gade
Srinivasa Reddy Mallepalli
Nageswara Rao Koduri
Ravindranath Tagore Amirisetty
Sri Hari Babu Karrothu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr, Sonny Sebastian, Srinivas Reddy Gade, Srinivasa Reddy Mallepalli, Nageswara Rao Koduri, Ravindranath Tagore Amirisetty, Sri Hari Babu Karrothu filed Critical Reddys Lab Ltd Dr
Publication of WO2007047838A2 publication Critical patent/WO2007047838A2/fr
Publication of WO2007047838A3 publication Critical patent/WO2007047838A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur un procédé de préparation de l'olmésartan médoxomil.
PCT/US2006/040883 2005-10-20 2006-10-18 Procede de preparation de l'olmesartan medoxomil WO2007047838A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1517/CHE/2005 2005-10-20
IN1517CH2005 2005-10-20
US74567006P 2006-04-26 2006-04-26
US60/745,670 2006-04-26

Publications (2)

Publication Number Publication Date
WO2007047838A2 WO2007047838A2 (fr) 2007-04-26
WO2007047838A3 true WO2007047838A3 (fr) 2007-12-06

Family

ID=37963278

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/040883 WO2007047838A2 (fr) 2005-10-20 2006-10-18 Procede de preparation de l'olmesartan medoxomil

Country Status (1)

Country Link
WO (1) WO2007047838A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0710905D0 (en) * 2007-06-07 2007-07-18 Generics Uk Ltd Amorphous olmesartan medoxomil
CN102083823B (zh) 2008-06-09 2015-10-07 第一三共株式会社 1-联苯甲基咪唑化合物的制备方法
SI2334668T1 (sl) * 2008-09-05 2014-08-29 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek priprave intermediata olmesartan medoksomila
EP2426126B1 (fr) 2009-04-28 2014-11-19 Daiichi Sankyo Company, Limited Procédé de production de l'olmésartan médoxomil
EP2426127B1 (fr) * 2009-04-28 2019-09-04 Daiichi Sankyo Company, Limited Nouveaux cristaux solvates
WO2011007368A2 (fr) 2009-07-14 2011-01-20 Cadila Healthcare Limited Procédé amélioré de préparation d'olmésartan
WO2011021224A2 (fr) * 2009-08-19 2011-02-24 Msn Laboratories Limited Procédé de préparation de (5-méthyl-2-oxo- 1,3-dioxolen-4-yl)méthyl-4-(1-hydroxy- 1 -méthyléthyl)-2-propyl- l-[4-[2-(tétrazol-5-yl)phényl]phényl]méthyl imidazole-5-carboxylate
WO2011045760A2 (fr) 2009-10-13 2011-04-21 Ranbaxy Laboratories Limited Compositions d'olmésartan médoxomil micronisé
AR083523A1 (es) 2010-10-29 2013-03-06 Interquim Sa Procedimiento de obtencion del olmesartan medoxomilo
US20150225380A1 (en) 2012-08-22 2015-08-13 Lupin Limited Novel Method to Obtain Olmesartan Medoxomil With Reduced Particle Size
JP6382660B2 (ja) * 2014-09-24 2018-08-29 株式会社トクヤマ オルメサルタンメドキソミルの製造方法
CN106749195A (zh) * 2016-12-30 2017-05-31 青岛黄海制药有限责任公司 一种奥美沙坦酯中间体杂质合成、鉴定的方法
CN112337419B (zh) * 2020-10-27 2022-05-13 浙江花蝶染料化工有限公司 一种4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459148A (en) * 1992-12-17 1995-10-17 Sankyo Company, Limited Biphenyl derivatives and their use for the treatment of hypertension and cardiac disease
US5646171A (en) * 1991-02-21 1997-07-08 Sankyo Company, Limited Angiotensin II antagonist 1-biphenylmethylimidazole compounds and their therapeutic use
US5674879A (en) * 1993-09-24 1997-10-07 G.D. Searle & Co. Compositions including and methods of using conformationally restricted angiotensin II antagonist
US6878703B2 (en) * 2000-11-21 2005-04-12 Sankyo Company, Limited Pharmaceutical composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646171A (en) * 1991-02-21 1997-07-08 Sankyo Company, Limited Angiotensin II antagonist 1-biphenylmethylimidazole compounds and their therapeutic use
US5459148A (en) * 1992-12-17 1995-10-17 Sankyo Company, Limited Biphenyl derivatives and their use for the treatment of hypertension and cardiac disease
US5674879A (en) * 1993-09-24 1997-10-07 G.D. Searle & Co. Compositions including and methods of using conformationally restricted angiotensin II antagonist
US6878703B2 (en) * 2000-11-21 2005-04-12 Sankyo Company, Limited Pharmaceutical composition

Also Published As

Publication number Publication date
WO2007047838A2 (fr) 2007-04-26

Similar Documents

Publication Publication Date Title
WO2007047838A3 (fr) Procede de preparation de l'olmesartan medoxomil
HK1115118A1 (en) Benzimidazole derivative and its use as aii receptor antagonist
WO2004096798A3 (fr) Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique
WO2009013211A3 (fr) Nouveaux dérivés pyrazolés
DE502005010105D1 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE50309807D1 (de) Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE502005007786D1 (de) Ausgewahlte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
RS54904B1 (sr) Antibakterijske farmaceutske kompozicije
AU2003238597A1 (en) Benzimidazole compounds and their use as estrogen agonists/antagonists
PT1499316E (pt) Derivados de (1-4-piperidinil)benzimidazole úteis como antagonistas de histamina h3
IS8291A (is) Pýrról-2,5-tvíþíónafleiður sem lifrar X viðtakastillar
DE602006019731D1 (de) 2,6-chinolinderivate sowie verfahren zu ihrer herstellung und verwendung als arzneimittel
WO2006107062A3 (fr) Derive de benzimidazole et utilisation de celui-ci
WO2009080721A3 (fr) Dérivés de 4-aminopyridine
WO2007056091A3 (fr) Antagonistes des recepteurs p2x7 et utilisations associees
TN2009000040A1 (en) 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
IL174762A (en) Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker and uses thereof
ZA200903578B (en) Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
WO2011021224A3 (fr) Procédé de préparation de (5-méthyl-2-oxo- 1,3-dioxolen-4-yl)méthyl-4-(1-hydroxy- 1 -méthyléthyl)-2-propyl- l-[4-[2-(tétrazol-5-yl)phényl]phényl]méthyl imidazole-5-carboxylate
WO2006052461A3 (fr) Nouvelles formulations d'eprosartan presentant une biodisponibilite amelioree
WO2011007368A3 (fr) Procédé amélioré de préparation d'olmésartan
WO2008027523A3 (fr) Sels d'éthers benzimidazolyle pyridyle et formulations associées
IL181683A0 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2004075892A3 (fr) Traitement combine de l'hypertension au moyen de lercanidipine et d'un bloqueur des recepteurs de l'angiotensine ii
SE0302571D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1920/CHENP/2008

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06826274

Country of ref document: EP

Kind code of ref document: A2